Article: NAD+ Precursors Restore Mitochondrial Function and Prevent Nerve Damage in Diabetes: Preclinical Findings

PrevNext
Diabetes Metabolic Health Neurological Health Neuropathy Preclinical

NAD+ Precursors Restore Mitochondrial Function and Prevent Nerve Damage in Diabetes: Preclinical Findings

Synopsis

Diabetic peripheral neuropathy involves nerve degeneration linked to low NAD+ levels. Researchers tested whether NAD+ precursors nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) could prevent neuropathy in mouse and rat diabetes models. Treatment improved nerve function, prevented nerve fiber loss, and restored mitochondrial capacity in nerve cells, without affecting blood sugar or insulin. This suggests boosting NAD+ in nerves may be enough to protect against diabetic neuropathy.

Journal

International Journal of Molecular Sciences

Share

Read more

Digestive/Gut Health

Nicotinamide Riboside Protects Against Experimental Necrotizing Enterocolitis: Preclinical Findings

Synopsis Necrotizing enterocolitis (NEC) is a life-threatening intestinal disease that affects newborns, often due to oxidative stress and poor blood flow in the gut. This study found that nicotin...

Read more
Cardiovascular Disease

Nicotinamide Riboside Protects Heart Function and Survival After Circadian Disruption: Preclinical Findings

Synopsis The circadian clock, which regulates daily biological rhythms, also plays an important role in heart health. In this study, mice lacking REV-ERB receptors—key circadian regulators in the ...

Read more